Video | July 12, 2021

CEO Perspectives On The Different Methods Of Going Public

Source: Life Science Leader

In this executive virtual roundtable (EVR) segment, an audience question asks for perspectives on the different methods of taking a company public. Roger Crystal, M.D., CEO of Opiant Pharmaceuticals; Ivana Magovcevic-Liebisch, Ph.D., J.D., CEO of Vigil Neuroscience; and Frank Lee, CEO of Forma Therapeutics, weigh in.

View the full presentation here.